172 related articles for article (PubMed ID: 37439102)
1. pH/GSH dual-responsive supramolecular nanomedicine for hypoxia-activated combination therapy.
Du C; Wang C; Jiang SH; Zheng X; Li Z; Yao Y; Ding Y; Chen T; Yi H
Biomater Sci; 2023 Aug; 11(16):5674-5679. PubMed ID: 37439102
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy.
Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Dong CM; Yao Y
Acta Biomater; 2022 Jul; 146():396-405. PubMed ID: 35470074
[TBL] [Abstract][Full Text] [Related]
3. Ferrocene-containing polymersome nanoreactors for synergistically amplified tumor-specific chemodynamic therapy.
Wang Y; Zhang S; Wang J; Zhou Q; Mukerabigwi JF; Ke W; Lu N; Ge Z
J Control Release; 2021 May; 333():500-510. PubMed ID: 33848558
[TBL] [Abstract][Full Text] [Related]
4. A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy.
Hao Y; Gao Y; Fan Y; Zhang C; Zhan M; Cao X; Shi X; Guo R
J Nanobiotechnology; 2022 Jan; 20(1):43. PubMed ID: 35062953
[TBL] [Abstract][Full Text] [Related]
5. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
[TBL] [Abstract][Full Text] [Related]
6. GSH-Responsive Organosilica Hybrid Nanosystem as a Cascade Promoter for Enhanced Starvation and Chemodynamic Therapy.
Wu H; Li X; Liu S; Wang Q; Cao Y; Hao JN; Li Y
Adv Healthc Mater; 2023 Jan; 12(2):e2201262. PubMed ID: 36213949
[TBL] [Abstract][Full Text] [Related]
7. A bioresponsive diselenide-functionalized hydrogel with cascade catalytic activities for enhanced local starvation- and hypoxia-activated melanoma therapy.
Ding X; Zang M; Zhang Y; Chen Y; Du J; Yan A; Gu J; Li Y; Wei S; Xu J; Sun H; Liu J; Yu S
Acta Biomater; 2023 Sep; 167():182-194. PubMed ID: 37339693
[TBL] [Abstract][Full Text] [Related]
8. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
[TBL] [Abstract][Full Text] [Related]
9. A Glucose/Oxygen-Exhausting Nanoreactor for Starvation- and Hypoxia-Activated Sustainable and Cascade Chemo-Chemodynamic Therapy.
Guo Y; Jia HR; Zhang X; Zhang X; Sun Q; Wang SZ; Zhao J; Wu FG
Small; 2020 Aug; 16(31):e2000897. PubMed ID: 32537936
[TBL] [Abstract][Full Text] [Related]
10. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-Responsive Polymersome with Continuous Glutathione Depletion for Enhanced Photodynamic Therapy and Hypoxia-Activated Chemotherapy.
Cheng G; Tao S; Liu S; Wang P; Zhang C; Liu J; Hao C; Wang S; Guo D; Xu B
ACS Macro Lett; 2024 May; 13(5):599-606. PubMed ID: 38683197
[TBL] [Abstract][Full Text] [Related]
12. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
13. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
[TBL] [Abstract][Full Text] [Related]
14. GSH-Responsive and Hypoxia-Activated Multifunctional Nanoparticles for Synergetically Enhanced Tumor Therapy.
Liu C; Jia S; Tu L; Yang P; Wang Y; Ke S; Shi W; Ye S
ACS Biomater Sci Eng; 2022 May; 8(5):1942-1955. PubMed ID: 35357802
[TBL] [Abstract][Full Text] [Related]
15. Tirapazamine-loaded UiO-66/Cu for ultrasound-mediated promotion of chemodynamic therapy cascade hypoxia-activated anticancer therapy.
Yang L; Wang Z; Gong H; Gai S; Shen R
J Colloid Interface Sci; 2023 Mar; 634():495-508. PubMed ID: 36542978
[TBL] [Abstract][Full Text] [Related]
16. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
[TBL] [Abstract][Full Text] [Related]
17. Cascade-Enhanced Catalytic Nanocomposite with Glutathione Depletion and Respiration Inhibition for Effective Starving-Chemodynamic Therapy Against Hypoxic Tumor.
Zhang Y; Hu H; Deng X; Song Q; Xing X; Liu W; Zhang Y
Int J Nanomedicine; 2022; 17():5491-5510. PubMed ID: 36438608
[TBL] [Abstract][Full Text] [Related]
18. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
[TBL] [Abstract][Full Text] [Related]
19. Carrier-Free H
Yang T; Zhou M; Gao M; Qin W; Wang Q; Peng H; Yao W; Qiao L; He X
Small; 2023 Feb; 19(7):e2205692. PubMed ID: 36494182
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer.
Pan Y; Zhu Y; Xu C; Pan C; Shi Y; Zou J; Li Y; Hu X; Zhou B; Zhao C; Gao Q; Zhang J; Wu A; Chen X; Li J
ACS Nano; 2022 Nov; 16(11):19038-19052. PubMed ID: 36315056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
